SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-088155
Filing Date
2023-03-31
Accepted
2023-03-31 16:30:58
Documents
14
Period of Report
2023-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d472019d8k.htm   iXBRL 8-K 25286
2 EX-99.1 d472019dex991.htm EX-99.1 63948
6 GRAPHIC g472019g0331201501411.jpg GRAPHIC 4234
  Complete submission text file 0001193125-23-088155.txt   227269

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20230331.xsd EX-101.SCH 2859
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20230331_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20230331_pre.xml EX-101.PRE 11267
8 EXTRACTED XBRL INSTANCE DOCUMENT d472019d8k_htm.xml XML 3438
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36577 | Film No.: 23788307
SIC: 2834 Pharmaceutical Preparations